Genc Sulcebe

Histocompatibility testing (HT) plays an important role in determining the degree of human leukocyte antigen (HLA) matching between the solid organ recipients and their donors (1, 2). It also includes the donor-recipient cross-match testing (XMT) and anti-HLA antibody searches that are crucial examinations in solid organ transplantation, aiming to avoid hyperacute graft rejection and also to predict the immunological outcome of the graft (3-5). Histocompatibility testing for solid organ transplantation in Albania began in 2006, when a living donor kidney transplantation program was implemented at a national level. Since all of the patients from this country are referred to a single laboratory specialised in HT testing, the data obtained in this centre represent the real situation for kidne